UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Stokes Family Office LLC

Stokes Family Office LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 60.7% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,690 shares of the healthcare conglomerate’s stock after selling 4,158 shares during the quarter. Stokes Family Office LLC’s holdings in UnitedHealth Group were worth $1,416,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in the company. Bordeaux Wealth Advisors LLC increased its stake in UnitedHealth Group by 19.5% in the fourth quarter. Bordeaux Wealth Advisors LLC now owns 1,795 shares of the healthcare conglomerate’s stock valued at $945,000 after purchasing an additional 293 shares during the last quarter. 9258 Wealth Management LLC grew its position in shares of UnitedHealth Group by 7.3% during the fourth quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock worth $2,250,000 after acquiring an additional 290 shares during the last quarter. Benjamin F. Edwards & Company Inc. grew its position in shares of UnitedHealth Group by 24.6% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 38,486 shares of the healthcare conglomerate’s stock worth $20,261,000 after acquiring an additional 7,594 shares during the last quarter. SouthState Corp lifted its holdings in shares of UnitedHealth Group by 3.2% during the fourth quarter. SouthState Corp now owns 7,658 shares of the healthcare conglomerate’s stock worth $4,032,000 after purchasing an additional 241 shares during the period. Finally, Running Oak Capital LLC lifted its holdings in shares of UnitedHealth Group by 17.5% during the fourth quarter. Running Oak Capital LLC now owns 16,086 shares of the healthcare conglomerate’s stock worth $8,469,000 after purchasing an additional 2,400 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 0.1 %

Shares of UNH traded down $0.52 during trading on Friday, reaching $492.45. The company’s stock had a trading volume of 2,486,099 shares, compared to its average volume of 4,412,819. The company has a fifty day moving average of $483.02 and a two-hundred day moving average of $513.07. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a market cap of $453.09 billion, a price-to-earnings ratio of 30.10, a P/E/G ratio of 1.40 and a beta of 0.55. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the company posted $6.26 EPS. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on UNH. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 10th. Truist Financial reissued a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Piper Sandler raised their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Finally, Royal Bank of Canada dropped their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.